Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2026-05-11 @ 5:57 PM
Study NCT ID:
NCT06306560
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-03-12
First Post:
2024-02-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC.
Sponsor:
Harbin Medical University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MA-SCLC-II-018
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None